Drug makers shell out millions to influence Calif. drug-discount vote

Pharmaceutical companies have ponied up $72 million to try to defeat a California ballot initiative that would extend drug discounts to more uninsured people and allow consumers to sue drug makers whose products are sold at "unconscionable" prices." Pfizer, GlaxoSmithKline, Merck and Johnson & Johnson have each given almost $10 million to the campaign. By comparison, the industry contributed just $9.8 million to affect the 2004 federal elections.

- read this report from USA Today for more

Suggested Articles

What the NASH field needs, says Genfit CEO Pascal Prigent, is something like the Hb1Ac test for diabetes.

Blocking a newly discovered molecule produced by B cells could slow their flow into the brain and offer a new way to treat MS, a Canadian team found.

The action will see Kiadis switch its attention to earlier-stage natural killer cell therapies against solid tumors and hematological cancers.